Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000225898 is annotated as a **translin pseudogene**, lacking evidence of protein-coding capability[1]. Pseudogenes are genomic DNA sequences similar to normal genes but generally non-functional; the parental, functional Translin gene (TSN) encodes a DNA- and RNA-binding protein involved in genome stability, RNA interference pathways (as part of the C3PO complex), and cellular recombination events, but the pseudogene itself is not functional and not considered a druggable or therapeutic target in current biomedical frameworks[1][2][3]. Its utility is mainly limited to genomic studies, evolutionary biology, or potential regulatory RNA functions—not as a classical target in drug discovery. If you intended to query the functional “Translin”/TSN protein instead of the pseudogene, please specify, as these have different biological significance and implications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translin pseudogene.